| Application no. and date | 13753455.8 (espacenet) (Federated) (European Patent Register), 20130808 | | Patent/reg. no. and date | DK/EP 2882737, 20190220 | | Publication date | 20150617 | | Priority no. and date | US 201261681484 P, 20120809 | | EP pub. no. and date |
EP 2882737 20150617 | | Effective date | | | Applicant/owner | Celgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P67755DK01 | | Inventor | XU, Jean, 2 Cherry Tree Lane
Warren, NJ 07059, US,
COHEN, Benjamin, M., 32 Hillcrest Avenue
Cranford, NJ 07016, US,
TRAVERSE, John, F., 11 West Colfax Avenue
Roselle Park, NJ 07204, US,
LI, Ying, 20 Rahway Road
Millburn, New Jersey 07041, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 401/04 (2006.01) | | Title | FAST FORM AF (S)-3-(4-((4-MORPHOLINMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDIN-2,6-DION HYDROCHLORID | | Int. application no. | US2013054064 | | Int. publication no. | WO2014025964 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
